Market Place
Sourcing Support
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
DMF submissions in 2020: Industry sustains its filing momentum
In case you thought Covid-19 had slowed down the speed at
which generic active
pharmaceutical ingr
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Does the FDA promote European manufacturers over others? The ice-bucket challenge winner!
This
week, Phispers brings you a short analysis on how FDA might be promoting
European drugmakers ov
